versión impresa ISSN 0004-282X
Arq. Neuro-Psiquiatr. vol.67 no.2b São Paulo jun. 2009
Fulminant idiopathic intracranial hypertension in a pediatric patient following a minor head trauma
Hipertensão intracraniana idiopática fulminante em paciente pediátrico após traumatismo craniano leve
Jaime LinI; Joelma Karin Sagica FernandesII; Eliete Chiconelli FariaII; Ricardo Silva PinhoI; Marcelo Rodrigues MasruhaIII; Luiz Celso Pereira VilanovaIV
IPostgraduate Physician, Division of Child Neurology, Department of Neurology and Neurosurgery, Federal University of São Paulo (UNIFESP), São Paulo SP, Brazil
IIResident, Division of Child Neurology, Department of Neurology and Neurosurgery, Federal University of São Paulo (UNIFESP), São Paulo SP, Brazil
IIIAssociated Physician,Division of Child Neurology, Department of Neurology and Neurosurgery, Federal University of São Paulo (UNIFESP), São Paulo SP, Brazil
IVProfessor and Chairman, Division of Child Neurology, Department of Neurology and Neurosurgery, Federal University of São Paulo (UNIFESP), São Paulo SP, Brazil
Idiopathic intracranial hypertension (IIH) is a condition defined by elevated intracranial pressure but no clinical, laboratory, or radiographic evidence of responsible infection, vascular abnormality, space occupying lesion or hydrocephalus1. The incidence of IIH in the general population is 0,9 cases per 100,000 people annually. It is considered rare in children and exceedingly rare in infants and neonates. In pediatric population, there is no predilection toward females being more common in adolescents. The disease in post-pubertal children has a female predominance and association with obesity, similar to in adults1,2. Some conditions have been identified as causative agents of secondary pseudotumor cerebri, including certain medications (e.g. vitamin A/D, several antibiotics, steroids, retinoic acid, lithium), endocrine abnormalities, autoimmune disorders, anemias, and cranial venous outflow abnormalities. The role of associated diseases and medications seems to be stronger in children than in adults1,2. Atypical presentations include uncommon conditions leading to IIH or unusual clinical presentation other than the more typical progressive and insidious clinical course. The term fulminant idiopathic intracranial hypertension is reserved for those patients presenting with IIH with an acute presentation and rapidly progressive visual loss with very few cases reported so far3.
We present on a definite case of fulminant IIH in a 11 years-old boy after a minor head trauma.
An 11-year-old male patient was admitted with diplopia of one week' duration. The patient was born to non-consanguineous parents, with an uneventful gestational history. He was born by normal delivery, with an uneventful neonatal period. His early development was normal and also presented normal neuropsychomotor acquisitions. There was also, no family history of neurological diseases.
The patient was previously healthy without clinical history of any medical conditions, receiving neither prescribed medications nor over the counter medications. The patient was not receiving any type of vitamin replacement.
Fifteen days before the admission, the patient presented a minor head trauma while he was swimming. The trauma was described as very mild, during leisure activities, without any immediate complaints or needing any medical attendance. Four days after the head trauma, the patient start with vomits, several times a day, bilateral periorbitary moderate pain. One day later, the patient started with visual loss and diplopia.
On physical examination, he was noted to be in good overall condition showing a normal physical examination without fever or any other signs of infection. His height was 147 centimeters, weighting 54 kilograms, and with a body mass index of 25 (97 centile)
Laboratory evaluations, including a complete blood count, blood electrolytes, urea, creatinin and liver enzymes gave results at normal range.
Ophthalmologic evaluation revealed acute papilledema and diminished visual acuity.
Cranial MRI revealed signs of intracranial hypertension (Fig 3) but no signs of venous sinus thrombosis in the MRI venography. After neuroimaging procedures, a lumbar puncture was performed revealing an opening pressure of 80 cm H2O with normal CSF composition with no evidence of pleocytosis, elevated protein or low glucose.
Following the diagnosis of IIH acetazolamide treatment was prescribed associated with repetitive lumbar puncture in order to decrease the CSF pressure. Within a week the visual acuity improved, and one month later the patient was symptom free. The patient repeated fundoscopic evaluations were normal and he is currently under regularly clinical follow-up.
The hospital ethics commission approved this case report and the parents gave informed consent for publication.
Although IIH can occur at any age, it is far more common in female adults, mainly obese individuals. In childhood, it now appears that there is an increase incidence of IIH among adolescents (12-15 years) as compared to children (2-12 years)1. When considering only cases of fulminant IIH the presented case seems very different from current descriptions3.
Several theories have been proposed to explain the pathophysiology of IIH, including increased brain volume caused by increased water content, increase blood volume, increased rate of CSF formation and decrease rate of CSF absorption at the corionic villi4. It was also suggested that elevated intracranial venous pressure might be an universal mechanism in IIH leading to a rise in CSF and intracranial pressure by resisting CSF absorption5.
Currently, IIH is diagnosed as following: (1) symptoms and signs of generalized intracranial hypertension; (2) documented elevated ICP; (3) normal CSF composition; and (4) no evidence of hydrocephalus, mass, or structural or vascular lesions on brain MRI specifically, no evidence of cerebral venous thrombosis6. In order to identify cases of fulminant IIH, the following definitions are considered: (1) acute onset of symptoms and signs of intracranial hypertension; (2) less than 4 weeks between onset of initial symptoms and visual loss; (3) rapid worsening of visual loss; and (4) MRI and MRI venogram ruling out venous thrombosis3. Our patient, fulfilled all the diagnostic criteria for fulminant IIH.
Fulminant IIH usually, do not differ from those with typical IIH, except for the temporal profile and the visual loss. Typically, in cases of IIH, visual acuity is affected late in the course of IIH, in large series of patients, the prevalence of loss of visual acuity as a presenting feature of the illness is low, and usually, the deterioration of visual acuity is gradually experienced over a long period of time7,8.
Our patient presented with severe visual loss associated with vomits and diplopia only five days after a minor head trauma. Because of this atypical presentation a throughout workup ruling out a secondary cause of isolated raised ICP was performed (specifically for meningeal process and cerebral venous thrombosis).
Similar reports of fulminant IIH are exceedingly rare in the literature and the pathophysiology remains unknown9. Identifiable conditions have been associated with IIH, especially in pediatric patients, the most common of which include drugs (such as tetracyclines, vitamin A, steroids, and chemotherapy agents); infections (acute sinusitis, varicella, measles); and endocrine conditions1.
In adults, there is a well-established association between obesity and IIH. In children this association is usually found in older patients1. When taking it into account, our patient could not be considered obese, presenting a body mass index (IMC) of 25 (at 97 centile) classified as overweight. None of the other above-mentioned conditions was found in our patient.
In the clinical history, however, it was mentioned an episode of minor head trauma few days before the symptoms onset. Minor head trauma was previously reported in association with pediatric IIH but in most of the cases, later neuroimaging examinations demonstrated cerebral venous sinus thrombosis or cerebral edema1. In our patient, MRI and MRI venography ruled out any sings of cerebral edema or venous thrombosis.
In our patient, it was found in the MRI venography an asymmetry in the right transverse venous sinus. It is well known that the brain hemispheres are anatomically and functionally asymmetric and asymmetries are also usually find in the venous system10. In a study of 100 patients with normal MRI imaging of the brain, MRI venography revealed a dominant right transverse sinus in 59 patients, a dominant left transverse sinus in 30 and a co-dominant transverse sinus in ten11. In children, those asymmetries are also usually find, in a study of 50 children ranging from 3 months to 17 years old, MRI venography showed a dominant right transverse sinus in 27 (54%) patients, a dominant left transverse sinus in 18 (36%), 4 co-dominant transverse sinus and 1 absence of both transverse sinus10. Those asymmetries were not associated with clinical or neurological symptoms.
Kantarci et al. studied the correlation between venous sinus asymmetries through MRI venography and intraocular pressure measured through pneumotonometry in patients without neither neurological nor ophthalmologic diseases. As a general conclusion it stated that if the size of transverse sinus in one side is larger and its venous drainage is greater, intraocular pressure of this side is lower. It can be speculated that the transverse sinus sizes may be associated with pathogenesis of diseases with increased intraocular pressure such as glaucoma12.
Stating that slightly differences in the venous drainage due to transverse sinus asymmetries could be responsive to an idiopathic intracranial hypertension would be highly speculative and further studies in this direction is needed.
The syndrome of IIH is already known for over a century since its early descriptions by Quincke in 1893, and until nowadays it remains perplexing medical professionals worldwide with its variable underlying conditions, clinical presentation, and outcome. Herein we presented a unique case of fulminant IIH in a pediatric patient.
1. Rangwala LM, Liu GT. Pediatric idiopathic intracranial hypertension. Surv Ophtalmol 2007;59:597-617. [ Links ]
2. Youroukos S, Psychou F, Fryssiras S, Paikos P, Nicolaidou P. Idiopathic intracranial hypertension in children. J Child Neurol 2000;15:453-457. [ Links ]
3. Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology 2007;68: 229-232. [ Links ]
4. Tasdemir HA, Dilber C, Totan M, Onder A. Pseudotumor cerebri complicating measles: a case report and literature review. Brain Dev 2006;28:395-397. [ Links ]
5. Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 1996;46:198-202. [ Links ]
6. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002;59:1492-1495. [ Links ]
7. Corbett JJ, Savino PJ, Thompson S, et al. Visual loss in pseudotumor cerebri: follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982;39:461-473. [ Links ]
8. Rush JA. Pseudotumor cerebri: clinical profile and visual outcome in 63 patients. Mayo Clin Proc 1980;55:541-546. [ Links ]
9. Kidron D, Pomeranz S. Malignant pseudotumor cerebri: report of two cases. J Neurosurg 1989;71:443-445. [ Links ]
10. Widjaja E, Griffiths P. Intracranial MR venography in children: normal anatomy and variations. Am J Neuroradiol 2004;25: 1557-1562. [ Links ]
11. Surendrababu N, Livingstone R. Variations in the cerebral venous anatomy and pitfalls in the diagnosis of cerebral venous sinus thrombosis: low field MRI experience. Ind J Med Sci 2006;60:135-142. [ Links ]
12. Kantarci M, Dane S, Gumustekin K, et al. Relation between intraocular pressure and size of transverse sinuses. Neuroradiology 2005;47:46-50. [ Links ]
Received 6 October 2008, received in final form 19 January 2009.
Accepted 14 April 2009.
Dr. Jaime Lin - Division of Child Neurology / Department of Neurology and Neurosurgery / UNIFESP - Rua Botucatu 720 - 04023-900 São Paulo SP - Brasil. E-mail: email@example.com